乔姝 高娃 王露
摘要: 新型冠状病毒肺炎(COVID-19)疫情正在大流行并蔓延全球,人类健康正遭受巨大威胁,目前尚无治疗的特效药物。临床上,冠状病毒(SARS-CoV-2)感染可引起间质性病毒性肺炎和严重的“细胞因子风暴综合征”,其特征是激活白细胞介素6 (IL-6)引起严重的、致命的、不能有效控制的全身炎症反应,进而发展为内皮炎和全身性血栓,并导致器官衰竭和死亡。高危因素有高龄和慢性病如高血压、糖尿病以及心血管疾病等。对此我国主要是采用中西医联合对症治疗,疗效显著,并对健康人群疫苗接种进行有效预防;但对臭氧(O3)治疗的案例报道极少。本文通过查阅大部分外文文献,对臭氧(O3)对组织细胞的保护机制以及目前在COVID-19并发症治疗方面的研究现状做一综述,为防治新冠肺炎提供重要参考。
关键词:臭氧(O3)疗法;新型冠状病毒肺炎;可行性;探讨
【中图分类号】R563 【文献标识码】A 【文章编号】1673-9026(2021)15--03
Abstract:The COVID-19 pandemic is spreading around the world, posing a huge threat to human health with no specific drug to treat it. Clinically, novel coronavirus infection (SARS-COV-2) causes severe primary interstitial virulent pneumonia and ‘cytokine storm syndrome’, characterized by interleukin-6 (IL-6) activation triggering a severe and fatal uncontrolled systemic inflammatory response that progresses to endodermatitis and systemic thrombosis, leading to organ failure and death. Comorbidities such as advanced age, hypertension, diabetes and cardiovascular disease are high-risk factors. In this regard, China mainly uses the combination of traditional Chinese and western medicine for symptomatic treatment, with remarkable curative effect and effective prevention of healthy population vaccination; However, few cases of ozone (O3) therapy have been reported. This article reviews the mechanism of ozone (O3) protective effect in different tissues and current research status in the treatment of COVID-19 complications by reviewing most foreign literature, providing important reference for the prevention and treatment of COVID-19.
Keywords:Ozone (O3) therapy; COVID-19;Feasibility;Explore
一、COVID-19背景
COVID-19是冠状病毒2(SARS-CoV-2)导致的严重急性呼吸综合征;与SARS-CoV-2紧密相关的是两种蝙蝠衍生的冠状病毒,特别是与2002-2003年SARS流行病有关的SARS-CoV菌株类似[1]。表明具有较强的传染性和快速进展性。SARS-CoV-2除了主要的呼吸道途径传播,但SARS-CoV-2也在感染者的肠道、肾脏和汗腺中被找到,因此通过粪便、尿液和汗液排泄传播成为可能[2]。据估计,感染的平均潜伏期为6.4天,基本繁殖频率为(2.24-3.58天)[3]。 在COVID-19患者中,發热、咳嗽、咽痛是最常见的症状,重症可继续发展为呼吸窘迫,很少出现肾衰竭,提示以发热为主,但不是感染的主要症状,还有少数感染者出现头痛、咯血、腹泻,甚至存在无症状感染[4],还会出现一些较不常见易被忽视的症状,如感觉虚弱和疲劳、肌痛、寒战、呕吐和恶心[5]。……